Edison, NJ, United States of America

Kathleen McLaughlin

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2006.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kathleen McLaughlin: Innovator in Biochemical Processes

Introduction

Kathleen McLaughlin is a notable inventor based in Edison, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of processes that enhance the efficiency of chemical reactions.

Latest Patents

One of her key patents is titled "Process for reducing an alpha-keto ester." This innovative process involves preparing (R)-hydroxy ester from alpha-keto ester by adding the alpha-keto ester to a mixture that includes the ketoreductase enzyme and non-ketoreductase enzyme components. The ketoreductase enzyme utilized in this process has a molecular weight between 36,000 and 38,000, and features a specific N-terminal amino acid sequence.

Career Highlights

Kathleen is currently employed at Merck & Co., Inc., where she continues to advance her research and development efforts. Her work has led to the successful patenting of her innovative processes, showcasing her expertise in the field.

Collaborations

She has collaborated with esteemed colleagues, including Michael G. Sturr and Jeffrey C. Moore, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kathleen McLaughlin's contributions to biochemical processes exemplify her dedication to innovation in the field. Her patented work not only highlights her expertise but also reflects the collaborative spirit of her professional environment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…